The HIV prevention drug will be available in 120 countries, the US Food and Drug Administration (FDA) has approved a generic version of the HIV prevention vaccine, Kazakhstan reports. The annual rate of Lenacavira will exceed 40,146 Tenge. The drug is injected at long intervals and, according to two studies, almost completely prevents HIV infection. According to experts, a reasonable generic would provide prevention to up to 20 million people. The first shipments can start within a few weeks. News @kazinform.

The HIV prevention drug will be available in 120 countries, the US Food and Drug Administration (FDA) has approved a generic version of the HIV prevention vaccine, Kazakhstan reports. The annual rate of Lenacavira will exceed 40,146 Tenge. The drug is injected at long intervals and, according to two studies, almost completely prevents HIV infection. According to experts, a reasonable generic would provide prevention to up to 20 million people. The first shipments can start within a few weeks. News @kazinform.